At a glance
- Originator CJ HealthCare
- Developer HK inno.N
- Class Antineoplastics; Benzamides; Glutamates; Hypoxanthines; Pyrimidines; Pyrroles; Small molecules
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors; Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Mesothelioma; Non-small cell lung cancer
Most Recent Events
- 18 Jun 2020 CJ HealthCare is now called HK inno.N
- 05 Feb 2019 Chemical structure information added
- 28 Dec 2015 Launched for Mesothelioma in South Korea (IV) prior to December 2015 (CJ Healthcare pipeline, December 2015)